A. Rahman and D. Isenberg, Systemic Lupus Erythematosus, New England Journal of Medicine, vol.358, issue.9, pp.929-939, 2008.
DOI : 10.1056/NEJMra071297

R. Cervera, M. Khamashta, J. Font, G. Sebastiani, A. Gil et al., Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period, Medicine, vol.82, issue.5, pp.299-308, 2003.
DOI : 10.1097/01.md.0000091181.93122.55

T. Dorner, A. Jacobi, J. Lee, and P. Lipsky, Abnormalities of B cell subsets in patients with systemic lupus erythematosus, Journal of Immunological Methods, vol.363, issue.2, pp.187-197, 2011.
DOI : 10.1016/j.jim.2010.06.009

D. Eilat and Y. Naparstek, Anti-DNA autoantibodies: a puzzle of autoimmune phenomena, Immunology Today, vol.20, issue.8, pp.339-342, 1999.
DOI : 10.1016/S0167-5699(99)01457-7

M. Miyara, Z. Amoura, C. Parizot, C. Badoual, K. Dorgham et al., Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus, The Journal of Immunology, vol.175, issue.12, pp.8392-8400, 2005.
DOI : 10.4049/jimmunol.175.12.8392

J. Crispin and G. Tsokos, Interleukin-17-producing T cells in lupus, Current Opinion in Rheumatology, vol.22, issue.5, pp.499-503, 2010.
DOI : 10.1097/BOR.0b013e32833c62b0

S. Apostolidis, J. Crispin, and G. Tsokos, IL-17-producing T cells in lupus nephritis, Lupus, vol.178, issue.2, pp.120-124, 2011.
DOI : 10.1084/jem.20041257

L. Bennett, A. Palucka, E. Arce, V. Cantrell, J. Borvak et al., Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood, The Journal of Experimental Medicine, vol.149, issue.6, pp.711-723, 2003.
DOI : 10.1136/ard.58.5.309

L. Jeffery, F. Burke, M. Mura, Y. Zheng, O. Qureshi et al., 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, J Immunol, vol.1, issue.183, pp.5458-5467, 2009.

J. Mora, M. Iwata, and U. Von-andrian, Vitamin effects on the immune system: vitamins A and D take centre stage, Nature Reviews Immunology, vol.178, issue.9, pp.685-698, 2008.
DOI : 10.1038/nri2378

M. Linker-israeli, E. Elstner, J. Klinenberg, D. Wallace, and H. Koeffler, Vitamin D3 and Its Synthetic Analogs Inhibit the Spontaneous in Vitro Immunoglobulin Production by SLE-Derived PBMC, Clinical Immunology, vol.99, issue.1, pp.82-93, 2001.
DOI : 10.1006/clim.2000.4998

S. Chen, G. Sims, X. Chen, Y. Gu, and P. Lipsky, Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation, The Journal of Immunology, vol.179, issue.3, pp.1634-1647, 2007.
DOI : 10.4049/jimmunol.179.3.1634

I. Ben-zvi, C. Aranow, M. Mackay, A. Stanevsky, D. Kamen et al., The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus, PLoS ONE, vol.5, issue.2, p.9193, 2010.
DOI : 10.1371/journal.pone.0009193.t001

H. Amital, Z. Szekanecz, G. Szucs, K. Danko, E. Nagy et al., Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.1155-1157, 2010.
DOI : 10.1136/ard.2009.120329

M. Hochberg, Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.74, issue.9, p.1725, 1997.
DOI : 10.1002/art.1780400928

M. Petri, M. Kim, K. Kalunian, J. Grossman, B. Hahn et al., Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus, New England Journal of Medicine, vol.353, issue.24, pp.2550-2558, 2005.
DOI : 10.1056/NEJMoa051135

J. Souberbielle, J. Body, J. Lappe, M. Plebani, Y. Shoenfeld et al., Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice, Autoimmunity Reviews, vol.9, issue.11, pp.709-715, 2010.
DOI : 10.1016/j.autrev.2010.06.009

B. Hollis, J. Kamerud, S. Selvaag, J. Lorenz, and J. Napoli, Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer, Clin Chem, vol.39, pp.529-533, 1993.

L. Ritterhouse, S. Crowe, T. Niewold, D. Kamen, S. Macwana et al., Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.70, issue.9
DOI : 10.1136/ard.2010.148494

P. Wu, E. Rhew, A. Dyer, D. Dunlop, C. Langman et al., 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus, Arthritis & Rheumatism, vol.115, issue.10, pp.251387-1395, 2009.
DOI : 10.1002/art.24785

D. Kamen, G. Cooper, H. Bouali, S. Shaftman, B. Hollis et al., Vitamin D deficiency in systemic lupus erythematosus, Autoimmunity Reviews, vol.5, issue.2, pp.114-117, 2006.
DOI : 10.1016/j.autrev.2005.05.009

M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing et al., Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor, Immunity, vol.30, issue.6, pp.899-911, 2009.
DOI : 10.1016/j.immuni.2009.03.019

J. Lemire, J. Adams, R. Sakai, and S. Jordan, 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells., Journal of Clinical Investigation, vol.74, issue.2, pp.657-661, 1984.
DOI : 10.1172/JCI111465

W. Rigby, T. Stacy, and M. Fanger, Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)., Journal of Clinical Investigation, vol.74, issue.4, pp.1451-1455, 1984.
DOI : 10.1172/JCI111557

J. Lemire, J. Adams, V. Kermani-arab, A. Bakke, R. Sakai et al., 25- Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro, J Immunol, vol.1, issue.134, pp.3032-3035, 1985.

H. Reichel, H. Koeffler, A. Tobler, and A. Norman, 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes., Proceedings of the National Academy of Sciences, vol.84, issue.10, pp.3385-3389, 1987.
DOI : 10.1073/pnas.84.10.3385

W. Rigby, B. Yirinec, R. Oldershaw, and M. Fanger, Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations, European Journal of Immunology, vol.64, issue.4, pp.563-566, 1987.
DOI : 10.1002/eji.1830170420

E. Van-etten and C. Mathieu, Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts, The Journal of Steroid Biochemistry and Molecular Biology, vol.97, issue.1-2, pp.93-101, 2005.
DOI : 10.1016/j.jsbmb.2005.06.002

C. Daniel, N. Sartory, N. Zahn, H. Radeke, and J. Stein, Immune Modulatory Treatment of Trinitrobenzene Sulfonic Acid Colitis with Calcitriol Is Associated with a Change of a T Helper (Th) 1/Th17 to a Th2 and Regulatory T Cell Profile, Journal of Pharmacology and Experimental Therapeutics, vol.324, issue.1, pp.23-33, 2008.
DOI : 10.1124/jpet.107.127209

S. Gorman, L. Kuritzky, M. Judge, K. Dixon, J. Mcglade et al., Topically Applied 1,25-Dihydroxyvitamin D3 Enhances the Suppressive Activity of CD4+CD25+ Cells in the Draining Lymph Nodes, The Journal of Immunology, vol.179, issue.9, pp.6273-6283, 2007.
DOI : 10.4049/jimmunol.179.9.6273

G. Penna, A. Roncari, S. Amuchastegui, K. Daniel, E. Berti et al., Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory, Blood, vol.1, issue.106, pp.25-33490, 2005.

F. Baeke, H. Korf, L. Overbergh, A. Verstuyf, L. Thorrez et al., The Vitamin D Analog, TX527, Promotes a Human CD4+CD25highCD127low Regulatory T Cell Profile and Induces a Migratory Signature Specific for Homing to Sites of Inflammation, The Journal of Immunology, vol.186, issue.1, pp.132-142, 2011.
DOI : 10.4049/jimmunol.1000695

P. Chiappetta, M. Roubaud, and B. Torresani, Blind Source Separation and the Analysis of Microarray Data, Journal of Computational Biology, vol.11, issue.6, pp.1090-1109, 2004.
DOI : 10.1089/cmb.2004.11.1090
URL : https://hal.archives-ouvertes.fr/hal-00350129

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-15550, 2005.
DOI : 10.1073/pnas.0506580102

V. Mootha, C. Lindgren, K. Eriksson, A. Subramanian, S. Sihag et al., PGC-1??-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nature Genetics, vol.34, issue.3, pp.267-273, 2003.
DOI : 10.1038/ng1180

C. Goulvestre, C. Chereau, C. Nicco, L. Mouthon, B. Weill et al., A Mimic of p21WAF1/CIP1 Ameliorates Murine Lupus, The Journal of Immunology, vol.175, issue.10, pp.6959-6967, 2005.
DOI : 10.4049/jimmunol.175.10.6959